News
Phase 1b/2a immune thrombocytopenia (ITP) trial FPI achieved, enrollment ongoing. Climb Bio is enrolling an open-label, dose-escalation Phase 1b/2a clinical trial of budoprutug in patients with ITP to ...
Q2 2025 Earnings Call Transcript August 8, 2025 Operator: Welcome to Globus Medical’s Second Quarter 2025 Earnings Call. [Operator Instructions]. I will now turn the call over to Brian Kearns, Senior ...
Clinical Trials of Budoprutug in Immune Thrombocytopenia (ITP) and Systemic Lupus Erythematosus (SLE) Underway; Trial of Budoprutug in Primary Membranous Nephropathy (pMN) Expected to Initiate in the ...
Early evidence of disease control was observed in the ongoing Phase 1 ACESOT-1051 trial, with three patients achieving stable disease in the 70 mg and 100 mg cohorts treated with the WEE1 inhibitor, ...
Q2 Revenue Growth of 2.5%, Currency Neutral Growth of 1.8%Q2 Annual Subscription Revenue Growth of 3.7%, Currency Neutral 3.0 ...
Detailed price information for Alpha Cognition Inc (ACOG-Q) from The Globe and Mail including charting and trades.
Detailed price information for Indie Semiconductor Cl A (INDI-Q) from The Globe and Mail including charting and trades.
Trump Media’s Bitcoin ETF filing sparks BTC rally talks. Will SEC approval trigger a breakout or stall the price? Expert ...
Man Utd see Carlos Baleba cash-plus-player bid rejected by Brighton - Paper Talk Plus: Chelsea join Man Utd in race to sign Gianluigi Donnarumma after PSG goalkeeper's Super Cup omission; Man City ...
21h
Consumer Queen on MSNHuge Price Drop on the NordicTrack Commercial Upright Cycle (70% Off!)Ready to level up your home workouts without breaking the bank? The NordicTrack Commercial VU 19 Upright Cycle just dropped from $999.99 to only $299.99. This deal is a serious game-changer for your ...
Newcastle United - get the latest NUFC news, Newcastle transfer news, fixtures, match reports, videos and photos from the Chronicle on ChronicleLive. You can also sign up to leave comments on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results